{"transactions":[{"id":778874,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:14:47.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001189124-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000118912426000002/ownership.xml","form_type":"4"}},{"id":1113189,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:28.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000066","document":"wk-form4_1749761417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000066/wk-form4_1749761417.xml","form_type":"4"}},{"id":1246505,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:01:55.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2466,"price":8.84,"value":21799.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11.16,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2466},"source":{"system":"sec-edgar","filing":"0000950170-25-027089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027089/ownership.xml","form_type":"4"}},{"id":1246504,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:01:55.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":2466},"source":{"system":"sec-edgar","filing":"0000950170-25-027089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027089/ownership.xml","form_type":"4"}},{"id":1246503,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:01:55.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":85.8,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":1541},"source":{"system":"sec-edgar","filing":"0000950170-25-027089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027089/ownership.xml","form_type":"4"}},{"id":1246502,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:01:55.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":672.9,"expiration_date":"2031-05-05","underlying":"Common Stock","underlying_shares":666},"source":{"system":"sec-edgar","filing":"0000950170-25-027089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027089/ownership.xml","form_type":"4"}},{"id":1246501,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T20:01:55.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":false,"nature":"The Barker/Loring Trust Dated August 27, 2013"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were disposed of pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, whereby, at the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of Issuer common stock were cancelled and automatically converted into the right to receive $20.00 per share in cash, without interest, less all applicable deductions and withholdings (the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of The Barker/Loring Trust and has voting and dispositive power with respect to these shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-027089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027089/ownership.xml","form_type":"4"}},{"id":1246500,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T20:01:55.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were disposed of pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, whereby, at the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of Issuer common stock were cancelled and automatically converted into the right to receive $20.00 per share in cash, without interest, less all applicable deductions and withholdings (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-027089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027089/ownership.xml","form_type":"4"}},{"id":1473028,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:22:53.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000034","document":"wk-form4_1718914965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000034/wk-form4_1718914965.xml","form_type":"4"}},{"id":1496794,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T18:30:49.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2025 Annual Meeting of Stockholders or May 29, 2025."}],"balance_after":74000,"derivative":{"exercise_price":0.372,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0000950170-24-067531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017024067531/ownership.xml","form_type":"4"}},{"id":1851917,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:14:30.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000051","document":"wf-form4_168694646055716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000051/wf-form4_168694646055716.xml","form_type":"4"}},{"id":1876705,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T17:02:06.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2024 Stockholder Annual Meeting or May 25, 2024."}],"balance_after":74000,"derivative":{"exercise_price":1.06,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001209191-23-032597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919123032597/doc4.xml","form_type":"4"}},{"id":2209176,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-11T20:51:12.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":44470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vested in equal monthly installments over a one year period such that the option became fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029."}],"balance_after":0,"derivative":{"exercise_price":0.51,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":44470},"source":{"system":"sec-edgar","filing":"0001411690-22-000016","document":"wf-form4_165757265259092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169022000016/wf-form4_165757265259092.xml","form_type":"4"}},{"id":2209175,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:51:12.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":44470,"price":0.51,"value":22679.7,"ownership":{"direct":true},"balance_after":58364,"source":{"system":"sec-edgar","filing":"0001411690-22-000016","document":"wf-form4_165757265259092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169022000016/wf-form4_165757265259092.xml","form_type":"4"}},{"id":2209255,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-11T19:00:48.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares are fully vested and may be exercised at any time."}],"balance_after":0,"derivative":{"exercise_price":0.63,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-041844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122041844/doc4.xml","form_type":"4"}},{"id":2209254,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T19:00:48.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":60000,"price":0.63,"value":37800.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-22-041844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122041844/doc4.xml","form_type":"4"}},{"id":2233985,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:29:32.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":164422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":164422,"derivative":{"exercise_price":1.62,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":164422},"source":{"system":"sec-edgar","filing":"0001209191-22-036320","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122036320/doc4.xml","form_type":"4"}},{"id":2251604,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T21:00:54.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2023 Stockholder Annual Meeting or May 26, 2023."}],"balance_after":46250,"derivative":{"exercise_price":2.86,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":46250},"source":{"system":"sec-edgar","filing":"0001209191-22-033015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122033015/doc4.xml","form_type":"4"}},{"id":2265557,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:16:54.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":10000,"price":1.6,"value":16000.0,"ownership":{"direct":true},"balance_after":13894,"source":{"system":"sec-edgar","filing":"0001209191-22-030026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122030026/doc4.xml","form_type":"4"}},{"id":2596045,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-19T21:49:40.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":40751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":40751,"derivative":{"exercise_price":5.34,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":40751},"source":{"system":"sec-edgar","filing":"0001209191-21-052603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121052603/doc4.xml","form_type":"4"}},{"id":2669985,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T23:19:11.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":7528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":7528,"derivative":{"exercise_price":7.64,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":7528},"source":{"system":"sec-edgar","filing":"0001209191-21-040409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121040409/doc4.xml","form_type":"4"}},{"id":3091482,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-03T00:26:50.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":44470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":44470,"derivative":{"exercise_price":0.51,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":44470},"source":{"system":"sec-edgar","filing":"0001209191-20-040750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120040750/doc4.xml","form_type":"4"}},{"id":3495618,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-10T21:33:03.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":21911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 6, 2020, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":21911,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":21911},"source":{"system":"sec-edgar","filing":"0001209191-19-035898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919119035898/doc4.xml","form_type":"4"}},{"id":3798453,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T20:42:02.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":10516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of October 1, 2018 (the \"Vesting Commencement Date\") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date."}],"balance_after":10516,"derivative":{"exercise_price":7.77,"expiration_date":"2028-09-30","underlying":"Common Stock","underlying_shares":10516},"source":{"system":"sec-edgar","filing":"0001209191-18-053847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118053847/doc4.xml","form_type":"4"}},{"id":3798452,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2018-10-03T20:42:02.000Z","date":"2018-08-21","kind":"purchase","acquired":true,"shares":3894,"price":6.47,"value":25194.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, were purchased in multiple transactions at prices ranging from $6.37 to $6.4971, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of units purchased at each separate price within the ranges set forth herein.\nUnits purchased at a price of $6.47 per unit, ."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"September 21, 2018 or such earlier date as Roth Capital Partners LLC, as representative of the underwriters in the Company's Initial Public Offering, shall determine."}],"balance_after":3894,"derivative":{"exercise_price":6.47,"expiration_date":"2023-08-21","underlying":"Common Stock","underlying_shares":3894},"source":{"system":"sec-edgar","filing":"0001209191-18-053847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118053847/doc4.xml","form_type":"4"}},{"id":3798451,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T20:42:02.000Z","date":"2018-08-21","kind":"purchase","acquired":true,"shares":3894,"price":6.47,"value":25194.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, were purchased in multiple transactions at prices ranging from $6.37 to $6.4971, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of units purchased at each separate price within the ranges set forth herein.\nUnits purchased at a price of $6.47 per unit, ."}],"balance_after":3894,"source":{"system":"sec-edgar","filing":"0001209191-18-053847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118053847/doc4.xml","form_type":"4"}}]}